CETUXIMAB COMBINED WITH INFUSIONAL 5-FLUOROURACIL/FOLINIC ACID AND OXALIPLATIN IN METASTATIC COLORECTAL CANCER: POOLED ANALYSIS OF COIN AND OPUS STUDY DATA

Míreanna comhchosúla

• Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.
  de réir: Madi, A, et al.
  Foilsithe / Cruthaithe: (2012)
• Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: The MRC COIN trial
  de réir: Madi, A, et al.
  Foilsithe / Cruthaithe: (2012)
• Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience.
  de réir: Adams, R, et al.
  Foilsithe / Cruthaithe: (2009)
• Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
  de réir: Adams, R, et al.
  Foilsithe / Cruthaithe: (2008)
• 5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation.
  de réir: Jebb, SA, et al.
  Foilsithe / Cruthaithe: (1994)